SeaCrest Wealth Management LLC Buys Shares of 330 VanEck Biotech ETF (NASDAQ:BBH)

SeaCrest Wealth Management LLC bought a new stake in shares of VanEck Biotech ETF (NASDAQ:BBHGet Rating) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 330 shares of the company’s stock, valued at approximately $48,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Fortitude Advisory Group L.L.C. boosted its holdings in shares of VanEck Biotech ETF by 58.5% during the 1st quarter. Fortitude Advisory Group L.L.C. now owns 393 shares of the company’s stock worth $64,000 after buying an additional 145 shares in the last quarter. First Republic Investment Management Inc. boosted its holdings in shares of VanEck Biotech ETF by 18.0% during the 1st quarter. First Republic Investment Management Inc. now owns 2,410 shares of the company’s stock worth $391,000 after buying an additional 367 shares in the last quarter. Bank of Montreal Can boosted its holdings in shares of VanEck Biotech ETF by 34.5% during the 1st quarter. Bank of Montreal Can now owns 1,802 shares of the company’s stock worth $295,000 after buying an additional 462 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of VanEck Biotech ETF by 95.9% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,001 shares of the company’s stock worth $146,000 after buying an additional 490 shares in the last quarter. Finally, Mogy Joel R Investment Counsel Inc. boosted its holdings in shares of VanEck Biotech ETF by 3.4% during the 1st quarter. Mogy Joel R Investment Counsel Inc. now owns 34,816 shares of the company’s stock worth $5,645,000 after buying an additional 1,145 shares in the last quarter. Institutional investors and hedge funds own 27.47% of the company’s stock.

VanEck Biotech ETF Stock Performance

VanEck Biotech ETF stock opened at $165.70 on Monday. VanEck Biotech ETF has a 52-week low of $131.12 and a 52-week high of $200.77. The stock’s 50 day moving average price is $150.49 and its two-hundred day moving average price is $149.41.

VanEck Biotech ETF Profile

(Get Rating)

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

Featured Stories

Want to see what other hedge funds are holding BBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Biotech ETF (NASDAQ:BBHGet Rating).

Institutional Ownership by Quarter for VanEck Biotech ETF (NASDAQ:BBH)

Receive News & Ratings for VanEck Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.